SCHEMBL6170179

SCHEMBL6170179

COC(=O)C=Cc1cc(Cl)ccc1[N+](=O)[O-]

nearest known ligand 0.66

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 6/20 0.62
ALDH1A1 P00352 2/20 0.50
MEN1 O00255 4/20 0.47
KMT2A Q03164 4/20 0.47
HPGD P15428 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
PSMD14 O00487 1/20 0.47
BLM P54132 1/20 0.47
STAT3 P40763 1/20 0.46
LMNA P02545 1/20 0.46
MAPK1 P28482 2/20 0.45
MAPT P10636 2/20 0.45
TSHR P16473 1/20 0.45
GAA P10253 1/20 0.45
POLB P06746 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6170174 1.00 BACE1 (0.62) BACE1ALDH1A1MEN1KMT2AHPGD
SCHEMBL9377330 0.89 BACE1 (0.49) BACE1ALDH1A1MEN1KMT2AHPGD
SCHEMBL9542727 0.89 BACE1 (0.49) BACE1ALDH1A1MEN1KMT2AHPGD
SCHEMBL6170004 0.84 BACE1 (0.54) BACE1ALDH1A1MEN1KMT2AHPGD
SCHEMBL3823935 0.84 BACE1 (0.54) BACE1ALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL6169997 0.84 BACE1 (0.54) BACE1ALDH1A1MEN1KMT2AHPGD
SCHEMBL6171194 0.84 BACE1 (0.54) BACE1ALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL6172741 0.83 BACE1 (0.68) BACE1ALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL6172745 0.83 BACE1 (0.68) BACE1ALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL6171630 0.83 DPP4 (0.46) BACE1ALDH1A1MEN1KMT2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1045833-B1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER (US) 2005-11-02 EP disclosed
US-6608070-B1 Useful for treatment of medical condition in which prostaglandins are implicated as pathogens NAKAO KAZUNARI (JP) 2003-08-19 US disclosed
EP-1065206-B1 Tetrazolylalkyl indole compounds as anti-inflammatory and analgesic agents PFIZER (US) 2002-10-09 EP disclosed
EP-1065206-A1 Tetrazolylalkyl indole compounds as anti-inflammatory and analgesic agents PFIZER INC. (US) 2001-01-03 EP disclosed
EP-1045833-A1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER INC. (US) 2000-10-25 EP disclosed
WO-1999035130-A1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER PHARMACEUTICALS INC. (JP) 1999-07-15 WO disclosed